Literature DB >> 20938995

Novel insights into the relationship between diabetes and osteoporosis.

Francisco J A de Paula1, Mark C Horowitz, Clifford J Rosen.   

Abstract

Only three decades ago adipose tissue was considered inert, with little relationship to insulin resistance. Similarly, bone has long been thought of purely in its structural context. In the last decade, emerging evidence has revealed important endocrine roles for both bone and adipose tissue. The interaction between these two tissues is remarkable. Bone marrow mesenchymal stem cells give rise to both osteoblasts and adipocytes. Leptin and adiponectin, two adipokines secreted by fat tissue, control energy homeostasis, but also have complex actions on the skeleton. In turn, the activities of bone cells are not limited to their bone remodelling activities but also to modulation of adipose cell sensitivity and insulin secretion. This review will discuss these new insights linking bone remodelling to the control of fat metabolism and the association between diabetes mellitus and osteoporosis.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20938995      PMCID: PMC3259009          DOI: 10.1002/dmrr.1135

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  90 in total

1.  Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls.

Authors:  Mitsuru Saito; Katsuyuki Fujii; Keishi Marumo
Journal:  Calcif Tissue Int       Date:  2006-09-11       Impact factor: 4.333

Review 2.  Convergence between bone and energy homeostases: leptin regulation of bone mass.

Authors:  Gerard Karsenty
Journal:  Cell Metab       Date:  2006-11       Impact factor: 27.287

3.  Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress.

Authors:  Yasuhiro Hamada; Sohei Kitazawa; Riko Kitazawa; Hideki Fujii; Masato Kasuga; Masafumi Fukagawa
Journal:  Bone       Date:  2006-12-24       Impact factor: 4.398

4.  Serum leptin and adiponectin are positively associated with bone mineral density at the distal radius in patients with type 2 diabetes mellitus.

Authors:  Tomoko Tamura; Masayasu Yoneda; Kiminori Yamane; Shuhei Nakanishi; Reiko Nakashima; Masamichi Okubo; Nobuoki Kohno
Journal:  Metabolism       Date:  2007-05       Impact factor: 8.694

5.  Lack of relationship between glycemic control and bone mineral density in type 2 diabetes mellitus.

Authors:  D M S L Cutrim; F A Pereira; F J A de Paula; M C Foss
Journal:  Braz J Med Biol Res       Date:  2007-02       Impact factor: 2.590

Review 6.  Mechanisms of disease: is osteoporosis the obesity of bone?

Authors:  Clifford J Rosen; Mary L Bouxsein
Journal:  Nat Clin Pract Rheumatol       Date:  2006-01

Review 7.  Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis.

Authors:  P Vestergaard
Journal:  Osteoporos Int       Date:  2006-10-27       Impact factor: 4.507

8.  Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

Authors:  Steven E Kahn; Steven M Haffner; Mark A Heise; William H Herman; Rury R Holman; Nigel P Jones; Barbara G Kravitz; John M Lachin; M Colleen O'Neill; Bernard Zinman; Giancarlo Viberti
Journal:  N Engl J Med       Date:  2006-12-04       Impact factor: 91.245

9.  Thiazolidinedione use and bone loss in older diabetic adults.

Authors:  Ann V Schwartz; Deborah E Sellmeyer; Eric Vittinghoff; Lisa Palermo; Beata Lecka-Czernik; Kenneth R Feingold; Elsa S Strotmeyer; Helaine E Resnick; Laura Carbone; Brock A Beamer; Seok Won Park; Nancy E Lane; Tamara B Harris; Steven R Cummings
Journal:  J Clin Endocrinol Metab       Date:  2006-04-11       Impact factor: 5.958

10.  The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial.

Authors:  Andrew Grey; Mark Bolland; Greg Gamble; Diana Wattie; Anne Horne; James Davidson; Ian R Reid
Journal:  J Clin Endocrinol Metab       Date:  2007-01-30       Impact factor: 5.958

View more
  54 in total

1.  High fat diet attenuates hyperglycemia, body composition changes, and bone loss in male streptozotocin-induced type 1 diabetic mice.

Authors:  Adriana Lelis Carvalho; Victoria E DeMambro; Anyonya R Guntur; Phuong Le; Kenichi Nagano; Roland Baron; Francisco José Albuquerque de Paula; Katherine J Motyl
Journal:  J Cell Physiol       Date:  2017-08-04       Impact factor: 6.384

2.  Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus.

Authors:  R Jiajue; Y Jiang; O Wang; M Li; X Xing; L Cui; J Yin; L Xu; W Xia
Journal:  Osteoporos Int       Date:  2014-04-24       Impact factor: 4.507

Review 3.  Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?

Authors:  G Targher; A Lonardo; M Rossini
Journal:  J Endocrinol Invest       Date:  2015-05-24       Impact factor: 4.256

4.  Runx2 regulates the gene network associated with insulin signaling and energy homeostasis.

Authors:  Mitra Adhami; Farah Y Ghori-Javed; Haiyan Chen; Soraya E Gutierrez; Amjad Javed
Journal:  Cells Tissues Organs       Date:  2011-05-20       Impact factor: 2.481

5.  Sex-specific relationships between insulin resistance and bone mineral content in Korean adolescents.

Authors:  Kayoung Lee
Journal:  J Bone Miner Metab       Date:  2012-10-18       Impact factor: 2.626

6.  Non-alcoholic fatty liver, adipose tissue, and the bone: a new triumvirate on the block.

Authors:  Giovanni Musso
Journal:  Endocrine       Date:  2012-07-18       Impact factor: 3.633

7.  Parathyroid hormone (1-34) promotes fracture healing in ovariectomized rats with type 2 diabetes mellitus.

Authors:  G Y Liu; G L Cao; F M Tian; H P Song; L L Yuan; L D Geng; Z Y Zheng; L Zhang
Journal:  Osteoporos Int       Date:  2017-08-14       Impact factor: 4.507

8.  New mutations at the imprinted Gnas cluster show gene dosage effects of Gsα in postnatal growth and implicate XLαs in bone and fat metabolism but not in suckling.

Authors:  Sally A Eaton; Christine M Williamson; Simon T Ball; Colin V Beechey; Lee Moir; Jessica Edwards; Lydia Teboul; Mark Maconochie; Jo Peters
Journal:  Mol Cell Biol       Date:  2012-01-03       Impact factor: 4.272

Review 9.  Muscle-bone and fat-bone interactions in regulating bone mass: do PTH and PTHrP play any role?

Authors:  Nabanita S Datta
Journal:  Endocrine       Date:  2014-05-07       Impact factor: 3.633

10.  Interactions between mesenchymal stem cells, adipocytes, and osteoblasts in a 3D tri-culture model of hyperglycemic conditions in the bone marrow microenvironment.

Authors:  Torri E Rinker; Taymour M Hammoudi; Melissa L Kemp; Hang Lu; Johnna S Temenoff
Journal:  Integr Biol (Camb)       Date:  2014-01-24       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.